BSE - Free Realtime Quote INR

Supriya Lifescience Limited (SUPRIYA.BO)

Compare
625.00 +1.15 (+0.18%)
As of October 31 at 3:29 PM GMT+5:30. Market Open.
Loading Chart for SUPRIYA.BO
DELL
  • Previous Close 623.85
  • Open 629.55
  • Bid 623.60 x --
  • Ask 624.95 x --
  • Day's Range 620.30 - 636.40
  • 52 Week Range 240.10 - 670.00
  • Volume 28,074
  • Avg. Volume 57,201
  • Market Cap (intraday) 50.302B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 32.00
  • EPS (TTM) 19.53
  • Earnings Date --
  • Forward Dividend & Yield 0.80 (0.13%)
  • Ex-Dividend Date Sep 20, 2024
  • 1y Target Est --

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India.

www.supriyalifescience.com

448

Full Time Employees

March 31

Fiscal Year Ends

Recent News: SUPRIYA.BO

View More

Performance Overview: SUPRIYA.BO

Trailing total returns as of 10/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SUPRIYA.BO
98.96%
S&P BSE SENSEX
9.90%

1-Year Return

SUPRIYA.BO
151.39%
S&P BSE SENSEX
23.83%

3-Year Return

SUPRIYA.BO
47.06%
S&P BSE SENSEX
37.12%

5-Year Return

SUPRIYA.BO
47.06%
S&P BSE SENSEX
37.12%

Compare To: SUPRIYA.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SUPRIYA.BO

View More

Valuation Measures

Annual
As of 10/31/2024
  • Market Cap

    50.21B

  • Enterprise Value

    49.39B

  • Trailing P/E

    31.93

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    8.21

  • Price/Book (mrq)

    5.54

  • Enterprise Value/Revenue

    8.07

  • Enterprise Value/EBITDA

    20.94

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    25.23%

  • Return on Assets (ttm)

    34.38%

  • Return on Equity (ttm)

    18.99%

  • Revenue (ttm)

    6.24B

  • Net Income Avi to Common (ttm)

    1.58B

  • Diluted EPS (ttm)

    19.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    843.14M

  • Total Debt/Equity (mrq)

    0.61%

  • Levered Free Cash Flow (ttm)

    374.79M

Company Insights: SUPRIYA.BO

People Also Watch